SignatureFD’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Buy |
662
+21
| +3% | +$907 | ﹤0.01% | 1880 |
|
|
2025
Q1 | $22.2K | Buy |
641
+488
| +319% | +$16.9K | ﹤0.01% | 2003 |
|
|
2024
Q4 | $4.2K | Buy |
153
+11
| +8% | +$302 | ﹤0.01% | 2650 |
|
|
2024
Q3 | $3.62K | Sell |
142
-7
| -5% | -$178 | ﹤0.01% | 2656 |
|
|
2024
Q2 | $3.77K | Sell |
149
-57
| -28% | -$1.44K | ﹤0.01% | 2601 |
|
|
2024
Q1 | $6.37K | Sell |
206
-8
| -4% | -$247 | ﹤0.01% | 2467 |
|
|
2023
Q4 | $8.64K | Buy |
214
+14
| +7% | +$565 | ﹤0.01% | 2316 |
|
|
2023
Q3 | $5.27K | Sell |
200
-14
| -7% | -$369 | ﹤0.01% | 2464 |
|
|
2023
Q2 | $3.68K | Buy |
214
+72
| +51% | +$1.24K | ﹤0.01% | 2613 |
|
|
2023
Q1 | $2.35K | Buy |
142
+35
| +33% | +$580 | ﹤0.01% | 2753 |
|
|
2022
Q4 | $815 | Sell |
107
-33
| -24% | -$251 | ﹤0.01% | 3012 |
|
|
2022
Q3 | $1K | Buy |
140
+92
| +192% | +$657 | ﹤0.01% | 2903 |
|
|
2022
Q2 | $0 | Sell |
48
-1,253
| -96% | – | ﹤0.01% | 3102 |
|
|
2022
Q1 | $13K | Buy |
+1,301
| New | +$13K | ﹤0.01% | 2022 |
|